Dr. Ashish “Ash” Dugar is a business leader with experience in clinical development & medical affairs, market access & health economics, commercial & business development, and new product assessment. He has a deep understanding of the global healthcare environment, market trends, and drug development. Ash is the Vice-President, Global Medical Affairs at Sarepta Therapeutics, a company leading the field in precision genetic medicine with one of the world’s largest RNA and Gene Therapy pipelines. Prior to his role at Sarepta, Ash was VP, Commercial Development at Intracellular Therapies where he was responsible for developing commercial and market access strategies. And before that role, he was the Global Head, Clinical Development Science & Innovation at Roche. Additionally, Ash was VP, Biosimilars for Cardinal Health (CAH) Specialty Solutions. And before joining CAH, Ash was Pfizer’s Vice-President, Global Head, Medicines Development Group for Biosimilars, where his team advanced Oncology and Autoimmune agents in the clinic.